Preprint Study Shows Increased Risk of Myocarditis Following Sequential COVID-19 Injections; Strongest Association in Males Under 40

A preprint released on December 25, 2021 analyzed the risk of myocarditis following multiple doses of the experimental COVID-19 injections. The study was conducted by UK researchers from institutions such as the University of Oxford, the University of Leicester, and the University of Edinburgh.

The researchers conducted a self-controlled case series analysis of over 42 million people age 13 or older. Their goal was to evaluate the association between COVID-19 inoculations and myocarditis. They categorized data by sex and age and included nearly 11 million people who received a third dose of the COVID-19 jabs.

The alarming results provide more evidence for regulators to halt these dangerous injections. The risk of myocarditis increased following multiple doses of the COVID-19 jabs, and the association was strongest in males under 40 years of age.

https://twitter.com/Gerard39delaney/status/1476939205909655552

Unless I am misreading these data, second and third doses of vaccine should be ceased for healthy males under 40 immediately. ⁦@sarahknapton⁩ ⁦@UsforThemUK⁩ https://t.co/mvYcevIjWo

— Hugh Osmond (@hughosmond) December 30, 2021

It would seem that healthy males under 40 should not be recommended to have multiple vaccine doses. Risks for this group from multiple jabs higher than from Covid. ⁦@CMO_England⁩ https://t.co/mvYcevIjWo

— Hugh Osmond (@hughosmond) December 30, 2021

I’ve had chest pains since my second jab months ago. 4/5 ‘episodes’ a day. Absolutely no chance am I pumping anymore in 👍🏼

— Ash Stephenson (@ashtoon92) December 31, 2021

https://twitter.com/james_doidge/status/1476474911451492352

https://twitter.com/KPCResearch/status/1476875872497975308

https://twitter.com/Overshoooot/status/1474912417578725377

Could this be another indicator that explains why so many professional athletes are dropping on the playing surface to cardiac issues?

Read the Abstract from the preprint study titled “Risk of myocarditis following sequential COVID-19 vaccinations by age and sex”

In an updated self-controlled case series analysis of 42,200,614 people aged 13 years or more, we evaluate the association between COVID-19 vaccination and myocarditis, stratified by age and sex, including 10,978,507 people receiving a third vaccine dose. Myocarditis risk was increased during 1-28 days following a third dose of BNT162b2 (IRR 2.02, 95%CI 1.40, 2.91). Associations were strongest in males younger than 40 years for all vaccine types with an additional 3 (95%CI 1, 5) and 12 (95% CI 1,17) events per million estimated in the 1-28 days following a first dose of BNT162b2 and mRNA-1273, respectively; 14 (95%CI 8, 17), 12 (95%CI 1, 7) and 101 (95%CI 95, 104) additional events following a second dose of ChAdOx1, BNT162b2 and mRNA-1273, respectively; and 13 (95%CI 7, 15) additional events following a third dose of BNT162b2, compared with 7 (95%CI 2, 11) additional events following COVID-19 infection. An association between COVID-19 infection and myocarditis was observed in all ages for both sexes but was substantially higher in those older than 40 years. These findings have important implications for public health and vaccination policy.